Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Sign Up to like & getrecommendations! Published in 2017 at "Bone"
DOI: 10.1016/j.bone.2017.07.005
Abstract: BACKGROUND Romosozumab is a monoclonal antibody that inhibits sclerostin and rapidly increases bone mineral density (BMD) through a dual effect on bone by increasing bone formation and decreasing bone resorption, as shown in a global… read more here.
Keywords: study; postmenopausal japanese; japanese women; phase study ... See more keywords
Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blind clinical trial
Sign Up to like & getrecommendations! Published in 2018 at "Bioscience of Microbiota, Food and Health"
DOI: 10.12938/bmfh.18-006
Abstract: Gut microbiota influence the host immune system and are associated with various diseases. In recent years, postmenopausal bone loss has been suggested to be related to gut microbiota. In the present study, we investigated the… read more here.
Keywords: group; postmenopausal japanese; bone; placebo ... See more keywords